Thalamic, pallidal, or subthalamic surgery for Parkinson's disease?

Area of Science:

• Neurosurgery
• Neurology
• Movement Disorders

Background:

• Levodopa is a primary treatment for Parkinson's disease (PD) motor symptoms.
• Long-term levodopa use often results in motor fluctuations and dyskinesias.
• Severe motor side effects may necessitate surgical intervention.

Purpose of the Study:

• To review surgical treatment options for Parkinson's disease motor complications.
• To compare the efficacy and safety of ablative surgery versus deep brain stimulation (DBS).
• To evaluate different surgical targets for Parkinson's disease (PD).

Main Methods:

• Review of ablative surgical techniques (thalamotomy, pallidotomy).
• Review of deep brain stimulation (DBS) targeting various brain regions.
• Comparison of outcomes based on surgical target: thalamus, globus pallidus, subthalamic nucleus.

Main Results:

• Thalamic surgery primarily improves tremor.
• Pallidal and subthalamic nucleus surgery improve all motor symptoms and levodopa-induced dyskinesias.
• Unilateral pallidotomy is effective and safe; bilateral DBS is feasible with lower morbidity.

Conclusions:

• Deep brain stimulation (DBS) targeting the subthalamic nucleus (STN) is a highly promising option for advanced Parkinson's disease (PD).
• Surgical interventions can significantly alleviate motor symptoms and levodopa-induced side effects in PD patients.
• The choice of surgical target influences the specific motor symptoms addressed.